IP Library › Granted Patent US 11,963,986
Granted Patent B2
US 11,963,986 · App. 17/287,719 · Granted Apr 23, 2024

Probiotic supplement for metabolic health

Inventors: Nanna Ny Kristensen (Bagsvaerd, DK); Alexandra Mattern (Berlin, DE); Delphine Marie Anne Saulnier (Berlin, DE); Jeffrey Schultchen (Berlin, DE); Teis Jensen (Bagsvaerd, DK); Benjamin Anderschou Holbech Jensen (Québec, CA)
Assignee: Novozymes A/S
A61K35/747A23L33/135A23L33/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,963,986
App. No.
17/287,719
Granted
Apr 23, 2024
Kind
B2
Abstract

The application discloses Lactobacillus strains having a beneficial effect on the metabolic health on a mammalian subject. Further disclosed is compositions comprising such strains and the use thereof for improving the metabolic health or for lowering the blood glucose level in a mammalian subject.

Claims (19)

1. A Lactobacillus strain selected from DSM 32910, DSM 32911, DSM 32851 and DSM 32853, wherein the strain is in freeze-dried from or spray-dried form.

2. The Lactobacillus strain according to claim 1 , wherein the strain has the ability of improving or alleviating one or more prediabetes symptoms selected from insulin resistance, high-blood glucose, low-grade inflammation and gut barrier function.

3. The Lactobacillus strain according to claim 1 , wherein the strain survives in the gastrointestinal (GI) tract.

4. The Lactobacillus strain according to claim 1 , wherein the strain is DSM 32851.

5. A composition comprising a Lactobacillus strain according to claim 1 .

6. The composition according to claim 5 , wherein the composition comprises 10 6 -10 14 colony forming units (CFU) of total Lactobacillus strain per gram of the composition.

7. A dietary supplement comprising a Lactobacillus strain according to claim 1 .

8. A method of improving the metabolic health of an individual, the method comprising administering to the individual in need of improving the metabolic health a Lactobacillus strain according to claim 1 .

9. The method of claim 8 , wherein improving the metabolic health is selected from alleviating prediabetes, preventing or alleviating type 2 diabetes, alleviating insulin resistance, improving liver health, reducing gut inflammation, improving gut barrier function, lowering blood glucose level, and preventing or reducing weight gain from a high fat diet.

10. The method of claim 8 wherein the individual is a human.

11. The composition according to claim 5 , wherein the composition comprises 10 7 -10 13 colony forming units (CFU) of total Lactobacillus strain per gram of the composition.

12. The composition according to claim 5 , wherein the composition comprises 10 8 -10 12 colony forming units (CFU) of total Lactobacillus strain per gram of the composition.

13. The composition according to claim 5 , wherein the composition comprises the Lactobacillus strain deposited as DSM 32851 and one or more Lactobacillus strains selected from the strains deposited as DSM 17648, DSM 32910, DSM 32911 and DSM 32853.

14. The composition according to claim 5 , wherein the composition comprises the Lactobacillus strain deposited as DSM 32910 and one or more Lactobacillus strains selected from the strains deposited as DSM 17648, DSM 32911, DSM 32851 and DSM 32853.

15. The Lactobacillus strain according to claim 1 , wherein the strain is in freeze-dried form.

16. The Lactobacillus strain according to claim 1 , wherein the strain is in spray-dried form.

17. The Lactobacillus strain according to claim 1 , wherein the strain is DSM 32910.

18. The Lactobacillus strain according to claim 1 , wherein the strain is DSM 32911.

19. The Lactobacillus strain according to claim 1 , wherein the strain is DSM 32853.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2021
From: SCHULTCHEN, JEFFREY; SAULNIER, DELPHINE MARIE ANNE; MATTERN, ALEXANDRA; KRISTENSEN, NANNA NY; JENSEN, TEIS; JENSEN, BENJAMIN ANDERSCHOU HOLBECH
To: NOVOZYMES A/S
Reel/Frame 056458/0569 →
Priority Claims (1)
EP 18202187 · Oct 24, 2018 · regional
Continuity (1)
Related Publication 20210393712A1 · Dec 23, 2021
Cited By (1)
US 12,616,726